Aileron Therapeutics
Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical t...
Aileron Therapeutics Logo
About Aileron Therapeutics
Rein Therapeutics, Inc. operates as a bio-pharmaceutical company. The Company focuses on advancing a novel pipeline of multi-pathway therapies that work at both an anti-fibrotic and regenerative level which helps in reducing scarring and promoting homeostasis. Rein Therapeutics serves customers worldwide.
Address
12407 N. Mopac Expy., Suite 250 #390
Austin, 78758
United States
Year founded
2001
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
